Bank Of America Corp Tyme Technologies, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.23 - $0.35 $50 - $76	-219 Reduced 12.72%	1,503 $0
Q1 2022 May 16, 2022	SELL	$0.28 - $0.68 $1,456 - $3,536	-5,201 Reduced 75.13%	1,722 $1,000
Q4 2021 Feb 08, 2022	SELL	$0.6 - $1.04 $6,834 - $11,845	-11,390 Reduced 62.2%	6,923 $4,000
Q3 2021 Nov 15, 2021	SELL	$0.99 - $1.38 $57,819 - $80,597	-58,404 Reduced 76.13%	18,313 $19,000
Q2 2021 Sep 13, 2021	BUY	$1.14 - $1.87 $87,457 - $143,460	76,717 New	76,717 $97,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.